Harmony Biosciences Files 8-K: Officer/Director Changes & Exhibits
Ticker: HRMY · Form: 8-K · Filed: Apr 14, 2026
Sentiment: neutral
Topics: officer-changes, director-changes, disclosure, exhibits
Related Tickers: HRMY
TL;DR
Harmony Bio (HRMY) filed an 8-K on 4/14/26 detailing leadership changes and new exhibits.
AI Summary
Harmony Biosciences Holdings, Inc. filed an 8-K on April 14, 2026, reporting changes in officers and directors under Item 5.02, a Regulation FD disclosure under Item 7.01, and financial statements/exhibits under Item 9.01. The filing includes exhibits such as EX-10.1, EX-10.2, and EX-99.1, along with interactive data files.
Why It Matters
This filing signals potential shifts in the company's leadership or governance structure and provides updated disclosures that could impact investor understanding of the company's operations.
Risk Assessment
Risk Level: low — The filing is a standard 8-K reporting routine changes and disclosures, not indicating immediate financial distress or significant operational disruption.
Key Numbers
- 15 — Documents (Number of documents included in the 8-K filing)
Key Players & Entities
- Harmony Biosciences Holdings, Inc. (company) — Filer of the 8-K
- 0001802665 (company) — CIK number for Harmony Biosciences Holdings, Inc.
- 2026-04-14 (date) — Filing date of the 8-K
- Item 5.02 (document_section) — Reporting departure of directors/officers and appointments
- Item 7.01 (document_section) — Regulation FD Disclosure
- Item 9.01 (document_section) — Financial Statements and Exhibits
FAQ
What specific changes were made regarding directors or officers?
The filing indicates Item 5.02 covers the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers', but the specific details would be within the referenced exhibits.
What is the purpose of the Regulation FD Disclosure (Item 7.01)?
Item 7.01 is for Regulation FD Disclosures, which ensures that material non-public information is disclosed to all investors simultaneously.
What types of exhibits are included in this filing?
The filing includes exhibits such as EX-10.1, EX-10.2, EX-99.1, and graphic files, as well as interactive data files (XBRL).
When was this 8-K filing accepted by the SEC?
The filing was accepted on 2026-04-14 at 08:15:10.
What is Harmony Biosciences Holdings, Inc.'s primary business according to the SIC code?
Harmony Biosciences Holdings, Inc. is classified under SIC code 2834, which pertains to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 14, 2026 regarding Harmony Biosciences Holdings, Inc. (HRMY).